We are building a pharmaceutical company around undiscovered biology, new genes and pathways, and turning them into targeted treatments.

Founded by two European entrepreneurs and operating in stealth across the United States and Europe, Pharmanautix is bringing together exceptional scientific and technical minds to transform how new medicines are discovered.

At the heart of our work is a proprietary Machine Learning platform built to uncover entirely new, previously undescribed molecular mechanisms and translate these discoveries into targeted therapeutics.

The next major breakthroughs in medicine will come from biology that remains unexplored. Our mission is to turn that unknown biology into new therapeutic possibilities, and ultimately make currently incurable diseases treatable.